THERMOGENESIS H.INC. NEW

THERMOGENESIS H.INC. NEW Share · US88362L2097 · THMO · A3D3XX (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of THERMOGENESIS H.INC. NEW
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
01.05.2026 18:55
Current Prices from THERMOGENESIS H.INC. NEW
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
THMO
USD
01.05.2026 18:55
0,000001 USD
-0,00010 USD
-99,00 %
OTC: UTC
UTC
THMO
USD
30.04.2026 20:00
0,0001 USD
0,00 USD
Share Float & Liquidity
Free Float 22,16 %
Shares Float 3,51 M
Shares Outstanding 15,85 M
Company Profile for THERMOGENESIS H.INC. NEW Share
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Company Data

Name THERMOGENESIS H.INC. NEW
Company ThermoGenesis Holdings, Inc.
Symbol THMO
Website https://www.thermogenesis.com
Primary Exchange XNCM Frankfurt
WKN A3D3XX
ISIN US88362L2097
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Xiaochun Xu
Country United States of America
Currency EUR
Employees 0,0 T
Address 2711 Citrus Road, 95742 Rancho Cordova
IPO Date 1987-06-05

Stock Splits

Date Split
22.12.2022 1:45
05.06.2019 1:10
07.03.2016 1:20
27.08.2010 1:4
17.06.1996 1:2

ID Changes

Date From To
01.11.2019 KOOL THMO

Ticker Symbols

Name Symbol
NASDAQ THMO
More Shares
Investors who hold THERMOGENESIS H.INC. NEW also have the following shares in their portfolio:
PICO FAR EAST HLD.SUBDIV.
PICO FAR EAST HLD.SUBDIV. Share
South West Pinnacle Exploration Limited
South West Pinnacle Exploration Limited Share